Transcranial magnetic stimulation potentiates glutamatergic neurotransmission in depressed adolescents
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Abnormalities in glutamate neurotransmission may have a role in the pathophysiology of adolescent depression. The present pilot study examined changes in cortical glutamine/glutamate ratios in depressed adolescents receiving high-frequency repetitive transcranial magnetic stimulation. Ten adolescents with treatment-refractory major depressive disorder received up to 30 sessions of 10-Hz repetitive transcranial magnetic stimulation at 120% motor threshold with 3,000 pulses per session applied to the left dorsolateral prefrontal cortex. Baseline, posttreatment, and 6-month follow-up proton magnetic resonance spectroscopy scans of the anterior cingulate cortex and left dorsolateral prefrontal cortex were collected at 3T with 8-cm3 voxels. Glutamate metabolites were quantified with 2 distinct proton magnetic resonance spectroscopy sequences in each brain region. After repetitive transcranial magnetic stimulation and at 6 months of follow-up, glutamine/glutamate ratios increased in the anterior cingulate cortex and left dorsolateral prefrontal cortex with both measurements. The increase in the glutamine/glutamate ratio reached statistical significance with the TE-optimized PRESS sequence in the anterior cingulate cortex. Glutamine/glutamate ratios increased in conjunction with depressive symptom improvement. This reached statistical significance with the TE-optimized PRESS sequence in the left dorsolateral prefrontal cortex. High-frequency repetitive transcranial magnetic stimulation applied to the left dorsolateral prefrontal cortex may modulate glutamate neurochemistry in depressed adolescents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Small sample inference for fixed effects from restricted maximum likelihood
Kenward, M. G., & Roger, J. H. (1997) · Biometrics · doi:10.2307/2533558 · Cited by 4,552
O’Reardon, J. P., Solvason, H. B., Janicak, P. G., Sampson, S., Isenberg, K. E., Nahas, Z., McDonald, W. M., Avery, D., Fitzgerald, P. B., Loo, C., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.018 · Cited by 1,910
Self-citationThe Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
Greenberg, P. E., Fournier, A.-A., Sisitsky, T., Pike, C. T., & Kessler, R. C. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09298 · Cited by 1,779 · cited 1×
“Major depressive disorder (MDD) frequently presents in adolescence and is often recalcitrant to treatment (Brent, 2009) which leads to substantial morbidity, mortality, and a societal financial burden (Blazer et al., 1994; Greenberg et al., 2015).”
Background(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.7.979 · Cited by 1,485 · cited 1×
“Major depressive disorder (MDD) frequently presents in adolescence and is often recalcitrant to treatment (Brent, 2009) which leads to substantial morbidity, mortality, and a societal financial burden (Blazer et al., 1994; Greenberg et al., 2015).”
BackgroundGeorge, M. S., Lisanby, S. H., Avery, D., McDonald, W. M., Durkalski, V., Pavlicova, M., Anderson, B., Nahas, Z., Bulow, P., Zarkowski, P., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.46 · Cited by 1,092 · cited 2×
“Prior research has shown that rTMS applied to the left dorsolateral prefrontal cortex (L-DLPFC) is a safe and effective treatment for MDD in adults who fail to benefit from antidepressant medications (O'Reardon et al., 2007; George et al., 2010).”
MethodTowards a glutamate hypothesis of depression
Sanacora, G., Treccani, G., & Popoli, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.036 · Cited by 1,036
Default mode network mechanisms of transcranial magnetic stimulation in depression
Liston, C., Chen, A. C., Zebley, B. D., Drysdale, A. T., Gordon, R., Leuchter, B., Voss, H. U., Casey, B. J., Etkin, A., & Dubin, M. J. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.023 · Cited by 763 · cited 1×
“Given the time and potential financial burden associated with an rTMS treatment course, predictive biomarkers are critical to identify patients most likely to benefit (Salomons et al., 2014; Liston et al., 2014).”
BackgroundGlutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments
Krystal, J. H., Sanacora, G., Blumberg, H., Anand, A., Charney, D. S., Marek, G., Epperson, C. N., Goddard, A., & Mason, G. F. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001021 · Cited by 553 · cited 1×
“Prior research implicates dysregulated glutamatergic neurotransmission in mood disorders (Krystal et al., 2002; Sanacora et al., 2012) and suggests that rTMS may modulate glutamatergic circuitry (Michael et al.”
BackgroundSalomons, T. V., Dunlop, K., Kennedy, S. H., Flint, A., Geraci, J., Giacobbe, P., & Downar, J. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.222 · Cited by 299 · cited 1×
“Given the time and potential financial burden associated with an rTMS treatment course, predictive biomarkers are critical to identify patients most likely to benefit (Salomons et al., 2014; Liston et al., 2014).”
BackgroundSafety of noninvasive brain stimulation in children and adolescents
Krishnan, C., Santos, L., Peterson, M. D., & Ehinger, M. (2015) · Brain stimulation · doi:10.1016/j.brs.2014.10.012 · Cited by 292 · cited 1×
“An enhanced understanding of brainbased therapeutic interventions in developing adolescents is an ethical, clinical, and scientific priority (Krishnan et al., 2015).”
BackgroundBrennan, B. P., Hudson, J. I., Jensen, J. E., McCarthy, J., Roberts, J. L., Prescot, A. P., Cohen, B. M., Pope, H. G., Renshaw, P. F., & Öngür, D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.191 · Cited by 168 · cited 1×
“To mitigate this measurement difficulty and improve sensitivity for detecting glutamate-glutamine cycle dysfunction, recently investigators have used the Gln/Glu ratio (Brennan et al., 2010; Ongur et al., 2011) or the Glu/Gln ratio (Hermann et al.”
MethodThe treatment of SSRI‐Resistant Depression in Adolescents (TORDIA): in search of the best next step
Brent, D. A. (2009) · Depression and Anxiety · doi:10.1002/da.20617 · Cited by 12 · cited 2×
“lescence and is often recalcitrant to treatment (Brent, 2009) which”
Background
Cited by
Transcranial Magnetic Stimulation for Adolescent Depression
Croarkin, P. E., & MacMaster, F. P. (2019) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2018.07.003 · Cited by 65
Self-citationQiu, H., Liang, K., Lu, L., Gao, Y., Li, H., Hu, X., Xing, H., Huang, X., & Gong, Q. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.09.060 · Cited by 41
Magavi, L. R., Reti, I. M., & Vasa, R. A. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1300574 · Cited by 41
“…trials, one case report) reported that rTMS may have a benefit for adolescent depression (Bloch et al., 2008; Cristancho, Akkineni, Constantino, Carter, & O’reardon, 2014; Croarkin et al., 2012, 2016; Loo et al., 2006; Mayer et al., 2012; Wall et al., 2011, 2013, 2016; Yang et al., 2014).”
MethodInfluentialHo, T. C., Teresi, G. I., Segarra, J. R., Ojha, A., Walker, J. C., Gu, M., Spielman, D. M., Sacchet, M. D., Jiang, F., Rosenberg-Hasson, Y., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.642976 · Cited by 32
Metadata
- Authors
- Croarkin, P. E., Nakonezny, P. A., Wall, C. A., Murphy, L. L., Sampson, S. M., Frye, M. A., & Port, J. D.
- Venue
- Psychiatry Research: Neuroimaging
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 247
- Pages
- 25-33
- ISSN
- 0925-4927 (ISSN-L)
- OpenAlex
- W2174033524
- Cited by
- 69
- References
- 13
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.